Having said the above, it is not the time and level to sell off your stake. In fact it is a good level for those without a stake to buy some. It is a good risk versus reward situation, the management notwithstanding. It was reported that the first patient did express shRNA and in the next cohort there is a good chance to see efficacy as the dosage is very much increased.
More of the same, page-12
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)